End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
2014 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Managers | Title | Age | Since |
---|---|---|---|
Karen Rogers
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | - | |
Corporate Officer/Principal | - | 31/12/96 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 31/08/06 | |
Director/Board Member | 70 | 24/09/13 |
1st Jan change | Capi. | |
---|---|---|
+0.10% | 91.42B | |
+3.16% | 41.08B | |
-11.10% | 34.26B | |
+53.99% | 25.27B | |
-9.41% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- Stock